Literature DB >> 32579190

Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life?

Amir B Rabbani1, Rushi V Parikh1, Asim M Rafique1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32579190     DOI： 10.1001/jamanetworkopen.2020.13556

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  10 in total

1.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

2.  Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials.

Authors:  Avinash Kumar Singh; Arya Vidyadhari; Harmandeep Singh; Kashif Haider; Anoop Kumar; Manju Sharma
Journal:  Clin Epidemiol Glob Health       Date:  2022-06-30

Review 3.  Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review.

Authors:  Adekunle Sanyaolu; Chuku Okorie; Aleksandra Marinkovic; Stephanie Prakash; Martina Williams; Nafees Haider; Jasmine Mangat; Zaheeda Hosein; Vyshnavy Balendra; Abu Fahad Abbasi; Priyank Desai; Isha Jain; Stephen Utulor; Amos Abioye
Journal:  Ther Adv Vaccines Immunother       Date:  2022-05-30

Review 4.  SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress.

Authors:  Ryan Chang; Abrar Mamun; Abishai Dominic; Nhat-Tu Le
Journal:  Front Physiol       Date:  2021-01-15       Impact factor: 4.566

5.  Immunomodulation and COVID-19: Is There a Winning Combination?

Authors:  Srinivas Samavedam
Journal:  Indian J Crit Care Med       Date:  2020-11

6.  Favipiravir and the Need for Early Ambulatory Treatment of COVID-19.

Authors:  Tony M Korman
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

7.  Colchicine, COVID-19 and hematological parameters: A meta-analysis.

Authors:  Musharraf Sarwar; Zahid Ali; Mahnoor Fatima; Zouina Sarfraz; Azza Sarfraz; Ivan Cherrez-Ojeda
Journal:  J Clin Lab Anal       Date:  2021-10-28       Impact factor: 2.352

Review 8.  Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports.

Authors:  R S Soumya; T Govindan Unni; K G Raghu
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-14       Impact factor: 3.727

Review 9.  Review of registered clinical trials for the treatment of COVID-19.

Authors:  Fatemeh Babaei; Mohammadreza Mirzababaei; Marjan Nassiri-Asl; Hossein Hosseinzadeh
Journal:  Drug Dev Res       Date:  2020-11-29       Impact factor: 5.004

Review 10.  Host-modifying drugs against COVID-19: some successes, but not yet the breakthrough.

Authors:  Harald Brüssow
Journal:  Environ Microbiol       Date:  2021-11-03       Impact factor: 5.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.